Provided by Tiger Trade Technology Pte. Ltd.

SPYRE THERAPEUTICS INC

88.71
+1.782.05%
Volume:902.46K
Turnover:79.43M
Market Cap:7.82B
PE:-44.14
High:88.72
Open:85.56
Low:85.26
Close:86.93
52wk High:110.18
52wk Low:14.51
Shares:88.17M
Float Shares:80.98M
Volume Ratio:0.82
T/O Rate:1.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0100
EPS(LYR):-1.9755
ROE:-22.98%
ROA:-19.81%
PB:8.19
PE(LYR):-44.91

Loading ...

Dec 22, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Dec 13, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 11, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Dec 08, 2023

Major Issues Report

Form 8-K - Current report
Dec 01, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 29, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Nov 28, 2023

Major Issues Report

Form 8-K - Current report
Nov 24, 2023

Major Issues Report

Form 8-K - Current report
Nov 17, 2023

Correspondence

Form CORRESP - Correspondence
Nov 15, 2023

Major Issues Report

Form 8-K - Current report
Nov 15, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Nov 15, 2023

Correspondence

Form CORRESP - Correspondence
Nov 14, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 09, 2023

Major Issues Report

Form 8-K - Current report
Nov 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 26, 2023

Correspondence

Form CORRESP - Correspondence
Oct 24, 2023

Major Issues Report

Form 8-K - Current report
Oct 10, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]